|
2018-09-18
|
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin
published
| article-journal
doi:10.1158/2159-8290.cd-17-0987
|
|
2018-12-21
|
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
published
| article-journal
| CC-BY
doi:10.17863/cam.34633
|
|
2019-06-17
|
Quantitative evidence for early metastatic seeding in colorectal cancer
published
| article-journal
doi:10.1038/s41588-019-0423-x
|
|
2019-04-01
|
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
published
| article-journal
doi:10.1038/s41582-019-0178-0
|
|
2019-01-15
|
Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases
published
| article-journal
doi:10.1158/1078-0432.ccr-18-1968
|
|
2020
|
Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2019-000623
|
|
2020-04-28
|
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation
published
| article-journal
| CC-BY
doi:10.3390/jcm9051272
|
|
2020
|
Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2020-000734
|
|
2020
|
How we treat patients with brain tumour during the COVID-19 pandemic
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2020-000789
|
|
2019-11-13
|
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open-Cancer Horizons pro and con discussion
published
| article-journal
doi:10.1136/esmoopen-2019-000565
|
|
2020-07-16
|
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation.
published
| article-journal
| CC-BY
doi:10.17863/cam.55143
|
|
2020
|
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2020-000880
|
|
2020-12-15
|
A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?
published
| article-journal
| CC-BY
doi:10.3390/cancers12123775
|
|
2019-07-05
|
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy
published
| article-journal
doi:10.1136/esmoopen-2019-000552
|
|
2019-07-17
|
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
published
| article-journal
doi:10.1136/esmoopen-2019-000538
|
|
2020-10-16
|
Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy
published
| article-journal
doi:10.1182/blood.2020007878
|
|
2020-04-01
|
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
published
| article-journal
doi:10.1158/2159-8290.cd-19-1030
|
|
2021-10-07
|
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
published
| article-journal
doi:10.1200/jco.21.00784
|
|
2022-01-05
|
Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years
published
| article-journal
| CC-BY
doi:10.1016/j.ejca.2021.12.005
|
|
2022-01-30
|
MR Fingerprinting—A Radiogenomic Marker for Diffuse Gliomas
published
| article-journal
| CC-BY
doi:10.3390/cancers14030723
|
|
2022-02-07
|
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
published
| article-journal
| CC-BY
doi:10.1016/j.ejca.2022.01.019
|
|
2021-10-21
|
Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey among EANO members
published
| article-journal
doi:10.1093/nop/npab059
|
|
2020
|
Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2020-000863
|
|
2020-12-22
|
Identification and characterization of cancer cells that initiate metastases to the brain and other organs
published
| article-journal
doi:10.1158/1541-7786.mcr-20-0863
|
|
2022-06-20
|
Dermatitis linearis outbreak associated with Paederus balcanicus in Austria
published
| article-journal
| CC-BY
doi:10.1007/s00508-022-02047-6
|
|
2022-07-07
|
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
published
| article-journal
doi:10.1093/noajnl/vdac112
|
|
2022-03-01
|
Enhanced expression of autophagy-related p62 without increased deposits of neurodegeneration-associated proteins in glioblastoma and surrounding tissue - An autopsy-based study
published
| article-journal
doi:10.1111/bpa.13058
|
|
2022-02-14
|
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: a joint EORTC BTG and RANO effort
published
| article-journal
doi:10.1093/neuonc/noac043
|
|
2022-08-01
|
Eano-Euracan-Sno Guidelines on Circumscribed Astrocytic GLIOMAS, Glioneuronal and Neuronaltumors
published
| article-journal
doi:10.1093/neuonc/noac188
|
|
2023-01-12
|
EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection
published
| article-journal
doi:10.1093/neuonc/noad008
|
|
2023-01-31
|
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.esmoop.2022.100776
|
|
2023-03-20
|
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
published
| unknown type
doi:10.21203/rs.3.rs-2663611/v1
|
|
2023-01-01
|
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma
published
| article-journal
| CC-BY-NC
doi:10.1093/noajnl/vdad136
|
|
2023-11-15
|
Prognosticators of survival in patients with metastatic pancreatic cancer and ascites
published
| article-journal
| CC-BY
doi:10.1016/j.esmoop.2023.102048
|
|
2023-10-13
|
Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer
published
| article-journal
| CC-BY
doi:10.1007/s12254-023-00916-y
|
|
2024-03-19
|
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial
published
| article-journal
doi:10.1093/neuonc/noae053
|
|
2024-03-19
|
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review
published
| article-journal
doi:10.1093/noajnl/vdae042
|
|
2023-11-09
|
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
published
| article-journal
doi:10.1038/s41591-023-02586-z
|
|
2024-06-08
|
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.7275861
|
|
2020
|
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2019-000647
|
|
2021-08-20
|
The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.ejca.2021.07.032
|
|
2021-05-06
|
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
published
| article-journal
doi:10.1007/s00262-021-02951-2
|
|
2022-02-25
|
Prognostic impact of genetic alterations and methylation classes in meningioma
published
| article-journal
| CC-BY
doi:10.1111/bpa.12970
|
|
2022-03-23
|
Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
published
| article-journal
| CC-BY
doi:10.1038/s41571-022-00623-3
|
|
2020-03-23
|
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma
published
| article-journal
doi:10.1038/s41588-020-0592-7
|
|
2022-08-23
|
Early postoperative treatment versus initial observation in CNS WHO grade 2 and 3 oligodendroglioma: clinical outcomes and DNA methylation patterns
published
| article-journal
doi:10.1158/1078-0432.ccr-22-1133
|
|
2022-08-08
|
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
published
| article-journal
| CC-BY
doi:10.1038/s41591-022-01935-8
|
|
2022-11-05
|
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: results of the EORTC SPECT-AYA international proof-of-concept study.
published
| article-journal
| CC-BY
doi:10.1016/j.ejca.2022.10.020
|
|
2022-12-23
|
Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?
published
| article-journal
doi:10.1093/neuonc/noac281
|
|
2023-07-24
|
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
published
| article-journal
doi:10.1038/s41591-023-02464-8
|
|
2023-07-21
|
What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?
published
| article-journal
doi:10.1093/neuonc/noad113
|
|
2023-09-26
|
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma
published
| article-journal
doi:10.1007/s00432-023-05424-4
|
|
2024-01-24
|
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper
published
| article-journal
doi:10.1111/all.15994
|
|
2023-11-15
|
A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses
published
| article-journal
doi:10.1093/neuonc/noad212
|
|
2024-03-01
|
Improving long-term outcomes in pediatric low-grade glioma
published
| article-journal
doi:10.1038/s43018-024-00741-0
|
|
2024-01-02
|
Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas
published
| article-journal
doi:10.1093/neuonc/noad228
|
|
2024-05-04
|
Radioligand therapies in meningioma - evidence and future directions
published
| article-journal
doi:10.1093/neuonc/noae069
|
|
2024-06-08
|
Additional file 1 of Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.25996845.v1
|
|
2024-06-08
|
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.7275861.v1
|
|
2024-07-02
|
Chairing Scientific Sessions at International Neuro-Oncology Meetings - an EANO guide for early career professionals
published
| article-journal
doi:10.1093/nop/npae060
|
|
2021-07-24
|
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases
published
| article-journal
doi:10.1016/j.clineuro.2021.106841
|
|
2021-10-19
|
Temporal muscle thickness as a prognostic marker in newly diagnosed glioblastoma patients: translational imaging analysis of the CENTRIC EORTC 26071-22072 and CORE trials
published
| article-journal
doi:10.1158/1078-0432.ccr-21-1987
|
|
2020-12-08
|
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
published
| article-journal
| CC-BY
doi:10.1038/s41571-020-00447-z
|
|
2021-10-21
|
Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
published
| article-journal
doi:10.1093/neuonc/noab243
|
|
2022-03-14
|
Opportunities and Challenges for the development of 'Core Outcome Sets' in Neuro-Oncology
published
| article-journal
doi:10.1093/neuonc/noac062
|
|
2022-08-19
|
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data
published
| article-journal
doi:10.1007/s10143-022-01849-6
|
|
2022-03-21
|
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma
published
| article-journal
doi:10.1093/neuonc/noac070
|
|
2022-10-20
|
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101
published
| article-journal
| CC-BY
doi:10.1016/j.ejca.2022.10.006
|
|
2022-08-12
|
European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL)
published
| article-journal
doi:10.1093/neuonc/noac196
|
|
2022-07-15
|
Depatuxizumab-mafodotin in <i>EGFR</i>-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial
published
| article-journal
doi:10.1093/neuonc/noac173
|
|
2023-02-27
|
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
published
| article-journal
doi:10.1093/neuonc/noad038
|
|
2023-08-15
|
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
published
| editorial
doi:10.1158/1078-0432.ccr-23-0020
|
|
2023-06-02
|
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
published
| article-journal
doi:10.1093/neuonc/noad100
|
|
2023-12-18
|
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: the EORTC 1608 STEAM trial
published
| article-journal
doi:10.1016/j.ejca.2023.113475
|
|
2023-10-03
|
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
published
| article-journal
| CC-BY
doi:10.1093/nop/npad064
|
|
2023-12-08
|
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center
published
| article-journal
doi:10.1007/s10585-023-10250-6
|
|
2023-09-29
|
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
published
| article-journal
doi:10.1200/jco.23.01059
|
|
2024-03-02
|
The outcomes measured and reported in intracranial meningioma clinical trials: a systematic review
published
| article-journal
doi:10.1093/noajnl/vdae030
|
|
2024-05-17
|
IDH inhibition in gliomas: from preclinical models to clinical trials
published
| article-journal
doi:10.1038/s41582-024-00967-7
|
|
2024-06-08
|
Additional file 1 of Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
published
| component
| CC-BY
doi:10.6084/m9.figshare.25996845
|
|
2024
|
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
published
| article-journal
doi:10.34734/fzj-2024-03598
|
|
2024-06-20
|
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
published
| article-journal
| CC-BY
doi:10.1007/s00259-024-06783-x
|
|
2023-03-20
|
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
published
| article-journal
| v1
doi:10.60692/rcnmc-cgk71
|
|
2024-08-06
|
Targeted radionuclide therapy for gliomas: emerging clinical trial landscape
published
| article-journal
doi:10.1093/neuonc/noae125
|
|
2023-08-15
|
Data from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
unknown status
| post
| CC-BY
doi:10.1158/1078-0432.c.6618078.v2
|
|
2024-10-01
|
Targeted radionuclide therapy for patients with CNS metastasis: overlooked potential?
published
| article-journal
doi:10.1093/neuonc/noae192
|
|
2024-11-22
|
EANO guideline on molecular testing of meningiomas for targeted therapy selection
published
| article-journal
doi:10.1093/neuonc/noae253
|
|
2024-11-11
|
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma
published
| article-journal
doi:10.1093/neuonc/noae209
|
|
2025-01-03
|
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.esmoop.2024.104092
|
|
2024
|
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
published
| article-journal
doi:10.1016/s1470-2045(23)00525-9
|
|
2024-05-02
|
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients
published
| article-journal
doi:10.1093/neuonc/noae082
|
|
2025-03-12
|
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung
published
| article-journal
| CC-BY
doi:10.1007/s12022-025-09847-2
|
|
2024-07-04
|
FINAL outcome ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-positive breast cancer PATIENTS WITH active brain metastases
published
| article-journal
doi:10.1093/neuonc/noae123
|
|
2024-03-15
|
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives
published
| article-journal
doi:10.1093/nop/npae023
|
|
2020
|
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
published
| article-journal
| CC-BY-NC
doi:10.1136/esmoopen-2020-000889
|
|
2024-09-05
|
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort
published
| article-journal
| CC-BY
doi:10.1007/s00508-024-02432-3
|
|
2024-09-16
|
Data from Frequent overexpression of HER3 in brain metastases from breast and lung cancer
unknown status
| post
| CC-BY
doi:10.1158/1078-0432.c.6618078
|
|
2024-10-03
|
Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases?
published
| article-journal
doi:10.1093/neuonc/noae202
|
|
2024-11-28
|
Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study
published
| article-journal
doi:10.1182/blood.2024025362
|
|
2024-11-19
|
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?
published
| article-journal
doi:10.1093/neuonc/noae225
|
|
2024-11-14
|
Who will benefit from vorasidenib? Review of data from the literature and open questions
published
| article-journal
doi:10.1093/nop/npae104
|
|
2024
|
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
published
| article-journal
doi:10.34734/fzj-2025-00580
|
|
2024-10-28
|
Radiotherapy for Meningiomas – Where Do We Stand and What's on the Horizon?
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.ijrobp.2024.10.034
|
|
2025-02-10
|
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1
published
| article-journal
doi:10.1093/neuonc/noae213
|
|
2024-06-07
|
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
published
| article-journal
| CC-BY
doi:10.1186/s13063-024-08213-7
|
|
2024-06-24
|
The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review
published
| article-journal
doi:10.1093/neuonc/noae107
|
|
2024-04-09
|
Locoregional delivery of CAR-T cells - breaking the spell in glioblastoma?
published
| article-journal
doi:10.1093/neuonc/noae063
|
|
2023-03-20
|
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
published
| article-journal
| v1
doi:10.60692/c80bp-qvx10
|
|
2024-08-10
|
European Association of Neuro-Oncology's 30th anniversary: A successful and growing relationship with <i>Neuro-Oncology Practice</i>
published
| article-journal
doi:10.1093/nop/npae061
|
|
2024-10-18
|
Correction to: Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort
published
| article-journal
| CC-BY
doi:10.1007/s00508-024-02456-9
|
|
2025-01-17
|
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?
published
| article-journal
doi:10.1093/nop/npaf006
|
|
2024-11-19
|
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments
published
| article-journal
doi:10.1093/neuonc/noae208
|
|
2025-01-03
|
Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.esmoop.2024.104093
|
|
2024
|
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
published
| article-journal
doi:10.34734/fzj-2024-04402
|
|
2024-03-02
|
Celebrating the 30th Anniversary of the European Association of Neuro-Oncology (EANO)
published
| article-journal
doi:10.1093/neuonc/noae039
|
|
2024-08-29
|
NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases
published
| article-journal
doi:10.1093/neuonc/noae171
|